Design and evaluation of sustained release matrix tablets of levofloxacin for effective treatment of microbial infections
Keywords:
Matrix tablets, levofloxacin, HPMC, guar gum, xantham gum, locust bean gum, Amorphophallus starchAbstract
The objective of present work was to formulate and evaluate sustained release matrix tablets of levofloxacin for treating microbial infections effectively. Levofloxacin is the active component of the racemate ofloxacin, and used for treating a variety of clinical conditions such as lower respiratory tract infections, acute sinusitis, uncomplicated skin and soft-tissue infections and complicated urinary tract infections. Different formulations were prepared by wet granulation method using various release rate controlling hydrophilic polymers. The formulations were evaluated for hardness, weight variation, friability and drug content uniformity. The in vitro release of drug from the formulations was studied in pH 1.2 acidic buffer and pH 6.8 phosphate buffer, and it was found that the prepared tablets were able to sustain the release of the drug. The release of levofloxacin from the tablets was diffusion controlled and the release mechanism was non-Fickian. For conclusion, the developed formulations may reduce the dosing intervals, reduce the dose related side effects and increase the drug’s efficacy for treating infections.
References
Ehrlich P. Immunology and cancer
research. In: collected papers of Paul
Ehrlich. Pergamon Press, London,
;pp.442.
George M, Grass IV, Robinson JR.
Sustained and Controlled Release Drug
Delivery Systems. Marcel Dekker, New
York 1978.
Hoffman A, Stepensky D.
Pharmacodynamic aspects of modes of
drug administration for optimization of
drug therapy. Crit. Rev. Ther. Drug
Carrier Syst. 1999;16:571–639.
Timmins P, Delargy AM, Minchom CM,
Howard R. Influence of some process
variables on product properties for a
hydrophilic matrix controlled release
tablet. Eur. J. Pharm. Biopharm.
;38:113-118.
Graham NB, McNeill ME. Hydrogels for
controlled drug delivery. Biomaterials
;5:27-36.
Sungthongjeen S, Pitaksuteepong T,
Somsiri A, Sriamornsak P. Studies on
pectins as potential hydrogel matrices for
controlled-release drug delivery. Drug
Dev. Ind. Pharm. 1999;25:1271-1276.
Oliphant CM, Green GM. Quinolones: A
comprehensive review. Am. Fam.
Physician 2002;65:455-464.
Hooper DC, Wolfson JS.
Fluoroquinolone antimicrobial agents. N.
Engl. J. Med. 1991;324:384-394.
Richeldi L, Covi M, Ferraro G, Franco F,
Vailati P, Meschiari E, Fabbri LM,
Velluti G. Clinical use of levofloxacin in
the long term treatment of drug resistant
tuberculosis. Monaldi. Arch. Chest Dis.
;57:39.
Neumann M. Clinical pharmacokinetics
of the newer antibacterial 4-quinolones.
Clin. Pharmacokinet. 1988;14:96-121.
Anonymous. Pharmacopoeia of India.
New Delhi: Ministry of Health and
Family Welfare, Government of India,
Controller of Publications 1996.
Tahara K, Yamamoto K, Nishihata T.
Application of model-independent and
model analysis for the investigation of
effect of drug solubility on its release rate
from hydroxypropyl methylcellulose
sustained release tablets. Int. J. Pharm.
;133:17-27.
Costa P, Lobo JMS. Modeling and
comparison of dissolution profiles. Eur. J.
Pharm. Sci. 2001;13:123-133.
Lachman L, Lieberman HA, Eds. The
Theory and Practice of Industrial
Pharmacy. Leas and Febiger,
Philadelphia, PA 1987.
Michael EA, Ed. Pharmaceutics. The
Science of Dosage Form Design.
Churchill Livingstone, London, UK 2002.
Amaral MH, Sousa JM, D. Ferreira DC.
Effect of hydroxypropyl methylcellulose
and hydrogenated castor oil on naproxen
release from sustained-release tablets.
AAPS Pharm. Sci. Tech. 2(2)
;Article 6.
Siepmann J, Peppas NA. Modeling of
drug release from delivery systems based
on hydroxypropyl methylcellulose. Adv.
Drug Del. Rev. 2001;48:139-157.
